This puts Genentec as owner of tecentric(Atezolizumab) in competition with Merck for IMU in a trial sense.
Merck being involved in keytruda combo trial.
Two HUGE Pharmas heavily invested in reviewing our IMU drugs.
I know we are all waiting but this is great news for cancer sufferers and means all majors are interested in what LC and team have put together.
I am a believer so I think its just amazing that a small company in essentially 6 years (since first trial of Hervaxx) has created so much value.
I dont think they have wasted a dollar of shareholders funds.
Lets hope the share price reflects this value I perceive soon.
GLTA shareholder
- Forums
- ASX - By Stock
- IMU
- Why IMU is a multi multi bagger
Why IMU is a multi multi bagger, page-12797
-
- There are more pages in this discussion • 13,180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
0.002(2.88%) |
Mkt cap ! $396.8M |
Open | High | Low | Value | Volume |
5.2¢ | 5.4¢ | 5.2¢ | $298.8K | 5.671M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 6972 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 838 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 1250199 | 0.053 |
20 | 2617025 | 0.052 |
43 | 4312182 | 0.051 |
70 | 5885827 | 0.050 |
17 | 2472174 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 1877567 | 23 |
0.055 | 1972756 | 15 |
0.056 | 2879641 | 14 |
0.057 | 790110 | 8 |
0.058 | 800800 | 6 |
Last trade - 15.59pm 27/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online